Sientra (SIEN) Earns Buy Rating from William Blair
Sientra (NASDAQ:SIEN)‘s stock had its “buy” rating reissued by analysts at William Blair in a report released on Thursday.
SIEN has been the subject of several other reports. BidaskClub upgraded shares of Sientra from a “sell” rating to a “hold” rating in a research note on Friday, December 15th. Zacks Investment Research upgraded shares of Sientra from a “sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. ValuEngine lowered shares of Sientra from a “hold” rating to a “sell” rating in a report on Thursday, February 22nd. Canaccord Genuity reissued a “buy” rating and issued a $19.00 price target on shares of Sientra in a report on Friday, January 5th. Finally, Lake Street Capital lowered shares of Sientra from a “buy” rating to a “hold” rating and lowered their price target for the company from $15.00 to $11.00 in a report on Wednesday, February 21st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $14.00.
Sientra (SIEN) opened at $9.74 on Thursday. The company has a market cap of $191.27, a price-to-earnings ratio of -3.42 and a beta of -1.10. Sientra has a one year low of $7.20 and a one year high of $16.68. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.92 and a current ratio of 2.87.
COPYRIGHT VIOLATION WARNING: “Sientra (SIEN) Earns Buy Rating from William Blair” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/sientra-sien-earns-buy-rating-from-william-blair/1905179.html.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.